1-1 of 1
Mirko Hirschl
Close
Sort by
Journal Articles

Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism

Clinical Trials & Observations
Sabine Eichinger, Verena Schönauer, Ansgar Weltermann, Erich Minar, Christine Bialonczyk, Mirko Hirschl, Barbara Schneider, Peter Quehenberger, Paul A. Kyrle
Journal: Blood
Blood (2004) 103 (10): 3773–3776.
https://doi.org/10.1182/blood-2003-10-3422
Published: 2004